CardioDiagnostics

CardioDiagnostics develops cloud-based and mobile technologies and analytics, empowering patients to take actionable steps to manage their chronic conditions. We focus on linking providers of care with patients seamlessly.

Our project has been in commercial deployment for six years now. The product is selling in the market using a business-to-business model, currently with 35 clients.

Our target customers include 5,000 hospitals and clinics in the US. Our market is essentially hospitals with cardiology divisions and added value services.

We are the first to bring our industry to the cloud by creating the world's first cloud-based cardiac monitoring software. The number of clients has been growing at 100% annually. The value we bring to our customers saves money and brings customers a competitive edge.

Our company creates customizable technology and services for cardiac monitoring as well as remote patient monitoring. The aim for our services is to allow physicians to onboard many more chronic condition patients than previously possible, while decreasing hospital readmissions and false negatives during diagnosis.

Not available.

We offer the world's first cloud-based software which is hardware-agnostic with customizable and flexible workflow.

We have four main streams of revenue:
1- Monitoring centers
2- Original equipment manufacturers
3- Large medical device companies
4- Hospitals and clinics

1- Growing the technology team to build complimentary products and services
2- Growing the sales network in the US

Possible risks include global economic crises or major regulatory changes.

UK-Lebanon Tech Hub, located in Lebanon and London, in 2015

Global Innovation Through Science and Technology Award
Stars of Science Award
Harvard Startup Pitch Award
UCSF Best Cardiovascular Digital Company Award